MTAP-NULL SOLID TUMORS

Clinical trials for MTAP-NULL SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new MTAP-NULL SOLID TUMORS trials appear

Sign up with your email to follow new studies for MTAP-NULL SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo targets Hard-to-Treat cancers in early trial

Disease control Ongoing

This early-stage study is testing a new combination of two oral drugs, AMG 193 and IDE397, for adults with advanced solid tumors that have a specific genetic feature called MTAP-null. The main goals are to find the safest and most effective dose and to see if the treatment can sh…

Matched conditions: MTAP-NULL SOLID TUMORS

Phase: PHASE1, PHASE2 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

MTAP-NULL SOLID TUMORS

Get alerted when new MTAP-NULL SOLID TUMORS trials appear

New drug duo targets Hard-to-Treat cancers in early trial